News / Events

Abeona Therapeutics Stakeholder Letter in Response to the COVID-19 Pandemic

Abeona Therapeutics Announces First Patient Treated in Pivotal Phase III Clinical Trial Evaluating EB-101 Gene Therapy for Recessive Dystrophic Epidermolysis Bullosa

Fourth Quarter & Full Year 2019 Earnings Call

Mar 17, 2020 • 10:00am EDT

9th Annual SVB Leerink Global Healthcare Conference

Feb 27, 2020 • 11:00am EDT